Evaluation of coronary stents: A review of types, materials, processing techniques, design, and problems

Fatemeh Ahadi1, Mohammad Azadi1, Mojtaba Biglari1

  • 1Faculty of Mechanical Engineering, Semnan University, Semnan, Iran.

Heliyon
|February 27, 2023
PubMed

Insights

Coronary artery disease (CAD) treatment often involves stents. This review analyzes stent biomechanics, materials, and designs to guide the development of more effective treatments for this leading cause of death.

Area of Science:

  • Biomedical Engineering
  • Cardiovascular Research
  • Materials Science

Background:

  • Coronary artery disease (CAD) is a leading global cause of mortality.
  • Stenting is a primary treatment for CAD, with increasing use of diverse stent models.
  • Understanding stent mechanical behavior is crucial for selecting appropriate devices.

Purpose of the Study:

  • To provide a comprehensive overview of advanced research on coronary stents.
  • To discuss and synthesize key studies on stent materials, design, and biomechanics.
  • To identify areas for future research in stent optimization.

Main Methods:

  • Literature review of biomechanical studies on coronary stents.
  • Classification of stents based on types, materials, processing, design, and expansion mechanisms.
  • Analysis of stent problems and complications.

Main Results:

  • Compilation of information on various coronary stent types, materials, and designs.
  • Overview of stent expansion mechanisms and associated complications.
  • Identification of research gaps in stent biomechanics and clinical-engineering.

Conclusions:

  • Biomechanical analysis is essential for designing more efficient coronary stents.
  • Future stent optimization requires continued research in simulation, numerical methods, and understanding artery biomechanics.
  • Interdisciplinary collaboration between clinical and engineering fields is vital for advancing stent technology.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
20
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
99
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
19
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
13
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
46
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
16